New resources to support Teva Pharmaceutical Industries' Tjet injector system now available

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today the availability of new resources to support the recently introduced Tjet® injector system, a needle-free device designed to deliver Teva’s TEV-TROPIN® [somatropin (rDNA origin) for injection] brand human growth hormone (hGH) to children who have growth failure due to inadequate secretion of normal endogenous growth hormone. The Tjet® device uses a needle-free delivery system that releases the same amount of TEV-TROPIN® as a traditional syringe in two seconds.

To help families with a growth hormone deficiency (GHD) diagnosis, Teva has launched an updated web site (http://tevtropin.com/) that includes information specifically tailored for kids, teens and parents, and caregivers; instructional videos to help families learn about the Tjet® device; and information about Growth Solutions®, the company’s comprehensive patient support program that offers training and education, as well as insurance and reimbursement assistance.

“The Tjet® device is a great option for children with growth hormone deficiency, especially those who dislike needles,” states Paul Saenger, M.D. “The families in my practice have found that the Tjet® is a kid-friendly way to administer the daily medication that their children need to help reach their normal heights.”

As part of its commitment to pediatric patient care, Teva will also provide the Tjet® device and replacement supplies free of charge with all prescriptions for TEV-TROPIN® when requested by a physician.

The Tjet® device works by releasing a thin stream of TEV-TROPIN® that penetrates the stratum corneum (outermost layer skin) and is delivered into the subcutaneous (below the skin) tissue in two seconds through a tiny opening in the skin less than one third the size of a 30-gauge needle. With flexible dosing in increments of 0.05 mg, the Tjet® device delivers the prescribed dose of TEV-TROPIN® with one click of a button. The Tjet® device can be used on the back of the upper arm, the upper outer thigh, stomach, or buttocks. The Tjet® device has an eco-friendly design that means less waste compared to needle-pen devices or traditional syringe administration.

SOURCE Teva Pharmaceutical Industries Ltd.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tertiary lymphoid structures linked to improved outcomes in liver cancer patients